One known mechanism for this resistance is deficient IFN signaling caused by the loss of ISG STAT1.6 ADAR1 deletion upregulates STAT1 and thus restores the sensitivity of tumor cells to IFN treatment. This evidence concerns the gene IFNA1 and neoplasm.